About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

As a key member of the Market Access leadership team, the Executive Director, Corporate Accounts leader will help lead the preparation, development, and execution of market access account strategies.. This is a critical customer facing role to helping to ensure broad access, reimbursement, and patient affordability. The individual will be responsible for building and maintaining relationships with key oncology stakeholders, including Specialty GPOs/Aggregators, Oncology Supergroups, Key Community Oncology practices, IDNs, Guideline and Pathway organizations. Additionally, the Executive Director, Corporate Accounts will lead the Corporate Accounts field account team and collaborate closely with Payer Strategic Accounts and sales teams, as well as internal teams, to integrate customer and market insights into pricing, contracting, and market access strategies and plans.

Role and Responsibilities:

Team Leadership: Build, train, and lead the account management field team (GPOs, Community Oncology, IDNs, and other Access Stakeholders) to develop and execute strategic business plans that align with overall objectives, maximize product access, and ensure reimbursement.
Stakeholder Engagement: Establish and maintain relationships with key decision-makers, including Formulary, P&T, and Pathway leaders, Medical & Pharmacy Directors and other population-based stakeholders to secure appropriate access and optimal product positioning.
Leadership and Influence: Demonstrate leadership among various customer groups and Access stakeholders, including GPOs, Community Oncology practices, IDNs, Pathway Committee members, and others (State Societies, COA, NCODA, etc.).
Cross-functional Collaboration: Partner with internal teams (Market Access, Medical Affairs, HEOR, Commercial Operations, Regulatory, Legal, Finance, Marketing, Sales, etc.) to address reimbursement challenges and develop coordinated solutions that are compliant and effective.
Strategy Development: Co-create strategies, tools, and tactics for the field team to communicate the product value proposition effectively and mitigate access barriers. Collaborate on pricing and contracting strategies, HEOR evidence generation plans, patient support programs, payer marketing initiatives, and account management approaches.
Alignment and Negotiation: Lead discussions with internal and external partners to ensure alignment on access, coverage, and reimbursement strategies.
Culture and Performance: Foster a high-performance culture within the field team by promoting accountability, urgency, partnership & collaboration, ethical behavior, and professional development.
Industry Insight: Stay informed on healthcare industry trends, payer policies, reimbursement processes, and competitive activity. Provide strategic insights to inform decision-making, access strategies, and product launches.
Compliance: Ensure all Market Access initiatives are developed and executed in compliance with legal, regulatory, and ethical standards.
All other duties as assigned

Experience, Education and Specialized Knowledge and Skills:

Bachelor’s degree in business, healthcare, or a related field; advanced degree preferred.
Minimum of 15+ years of experience in payer and/or GPO strategy, pricing, and reimbursement within the pharmaceutical industry
Minimum of 7+ years of focused account management experience in the oncology access marketplace
Demonstrated success in engaging with GPOs, Oncology Aggregator’s, Community Oncology Practices, and IDNs
Strong understanding of the US healthcare payer/access landscape and regulatory environment
Excellent strategic thinking, leadership, negotiation, and relationship management skills
Ability to lead cross-functional teams and drive complex projects to completion
Exceptional communication and presentation skills
Successful record of achieving and maintaining compliance with all applicable regulatory, legal, and operational rules
Proven ability to work effectively in a fast-pace and dynamic environment, balancing multiple priorities and meeting deadlines.
Travel: Ability to travel to support business priorities as needed

This is the pay for this position

Pay Transparency

$228,000—$285,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at [email protected] to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

Pay Transparency 228000 - 285000 USD

Summit Therapeutics

Executive Director – Corporate Accounts Lead

About the Job

Requirements

Responsibilities

Desired Qualifications

About the Company

Summit Therapeutics

Recently Posted Jobs